RNAC

RNAC Market Capitalization Overview
Market Cap: $195.45M as of Oct 27, 2026
$195.45M
$28.75M (12.82%)past month
As of Oct 27, 2026, RNAC has a market capitalization of $195.45M. Over the past 30 days, its market cap has decreased by -22.37%, while in the last 12 months, it has increased by 4.25%.
Market capitalization represents the total value of Cartesian Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RNAC Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RNAC helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Cartesian Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RNAC Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RNAC helps investors assess the company's size and compare it with competitors for better investment decisions.
RNAC Market Cap & Key Trends
See Cartesian Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in RNAC
Order type
Buy in
Order amount
Est. shares
0 shares
RNAC Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Oct 1, 2026 | $218.45M | -22.37% |
| Sep 1, 2026 | $281.38M | +21.69% |
| Aug 3, 2026 | $231.24M | -22.69% |
| Jul 1, 2026 | $299.11M | +47.11% |
| Jun 1, 2026 | $203.32M | +23.31% |
| May 1, 2026 | $164.89M | -2.66% |
| Apr 1, 2026 | $169.40M | -14.29% |
| Mar 2, 2026 | $197.63M | +11.93% |
| Feb 2, 2026 | $176.57M | +0.44% |
| Jan 2, 2026 | $175.79M | -7.40% |
RNAC End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $195.45M | +4.25% |
| 2025 | $187.49M | -59.31% |
| 2024 | $460.75M | +331.58% |
| 2023 | $106.76M | +23.47% |
| 2022 | $86.47M | -57.09% |
| 2021 | $201.51M | — |
FAQs About Cartesian Therapeutics Inc (RNAC) Market Cap
As of Oct 27, 2026, the market capitalization of RNAC is $195.45M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Cartesian Therapeutics Inc’s market capitalization has decreased by -12.82%, changing from $224.20M to $195.45M as of Oct 27, 2026.
In the last 3 months, Cartesian Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Cartesian Therapeutics Inc’s market capitalization decreased from $460.75M in January to $187.49M in December, reflecting a -59.31% change.
In the past five years, RNAC has had a compound annual growth rate (CAGR) of -1.43% in market capitalization. This means its market cap has shrunk at an average rate of -1.43% per year.
RNAC Market Cap & Key Trends
See Cartesian Therapeutics Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in RNAC
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.